Estée Lauder 10-Q 2024-03-31

Filed 2024-05-01. 7 sections, 348K characters. Original on sec.gov · Markdown · JSON

Cover and table of contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________________________________________________

FORM 10-Q

(Mark One)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

or

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-14064

The Estée Lauder Companies Inc.

(Exact name of registrant as specified in its charter)

Delaware11-2408943
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
767 Fifth Avenue, New York, New York10153
(Address of principal executive offices)(Zip Code)

212-572-4200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common Stock, $.01 par valueELNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer☒Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At April 24, 2024, 233,021,911 shares of the registrant’s Class A Common Stock, $.01 par value, and 125,542,029 shares of the registrant’s Class B Common Stock, $.01 par value, were outstanding.

THE ESTÉE LAUDER COMPANIES INC.

INDEX

Page
Part I. Financial Information
Item 1. Financial Statements (Unaudited)
Consolidated Statements of Earnings — Three and Nine Months Ended March 31, 2024 and 20232
Consolidated Statements of Comprehensive Income — Three and Nine Months Ended March 31, 2024 and 20233
Consolidated Balance Sheets — March 31, 2024 and June 30, 2023 (Audited)4
Consolidated Statements of Cash Flows — Nine Months Ended March 31, 2024 and 20235
Notes to Consolidated Financial Statements6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations40
Item 3. Quantitative and Qualitative Disclosures About Market Risk73
Item 4. Controls and Procedures73
Part II. Other Information
Item 1. Legal Proceedings73
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds74
Item 5. Other Information74
Item 6. Exhibits74
Signatures75

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

THE ESTÉE LAUDER COMPANIES INC.

CONSOLIDATED STATEMENTS OF EARNINGS

(Unaudited)

Three Months Ended March 31Nine Months Ended March 31
(In millions, except per share data)2024202320242023
Net sales$3,940$3,751$11,737$12,301
Cost of sales1,1071,1593,3313,401
Gross profit2,8332,5928,4068,900
Operating expenses
Selling, general and administrative2,2842,2817,1777,155
Restructuring and other charges18142624
Impairment of other intangible assets———207
Total operating expenses2,3022,2957,2037,386
Operating income5312971,2031,514
Interest expense9458287156
Interest income and investment income, net453712678
Other components of net periodic benefit cost(4)(4)(9)(9)
Earnings before income taxes4862801,0511,445
Provision for income taxes151125356403
Net earnings3351556951,042
Net loss (earnings) attributable to redeemable noncontrolling interest(5)1(21)(3)
Net earnings attributable to The Estée Lauder Companies Inc.$330$156$674$1,039
Net earnings attributable to The Estée Lauder Companies Inc. per common share
Basic$.92$.44$1.88$2.90
Diluted$.91$.43$1.87$2.88
Weighted average common shares outstanding
Basic359.1357.9358.8357.8
Diluted360.8361.2360.4360.9

See notes to consolidated financial statements.

THE ESTÉE LAUDER COMPANIES INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

Three Months Ended March 31Nine Months Ended March 31
(In millions)2024202320242023
Net earnings$335$155$695$1,042
Other comprehensive income (loss):
Net cash flow hedge gain (loss)21(43)(7)(50)
Cross-currency swap contract gain (loss)(4)(11)10(11)
Retirement plan and other retiree benefit adjustments

Showing the first 8K of 179K characters. Open the full section

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

RESULTS OF OPERATIONS

We manufacture, market and sell beauty products including those in the skin care, makeup, fragrance and hair care categories, which are distributed in approximately 150 countries and territories. The following table is a comparative summary of operating results for the three and nine months ended March 31, 2024 and 2023, and reflects the basis of presentation described in Notes to Consolidated Financial Statements, Note 1 – Summary of Significant Accounting Policies for all periods presented. Products and services that do not meet our definition of skin care, makeup, fragrance and hair care have been included in the “other” category. During the fiscal 2024 second quarter, we identified and corrected misclassifications of net sales and operating income between certain of our product categories in our Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended March 31, 2023. See Note 14 – Segment Data and Related Information for additional details.

Three Months Ended March 31Nine Months Ended March 31
(In millions)2024202320242023
NET SALES
By Product Category:
Skin Care$2,060$1,915$5,873$6,454
Makeup1,1361,1043,3653,424
Fragrance5755771,9481,907
Hair Care143148464488
Other26118838
3,9403,75511,73812,311
Returns associated with restructuring and other activities—(4)(1)(10)
Net sales$3,940$3,751$11,737$12,301
By Region**(1)****:**
The Americas$1,117$1,089$3,567$3,447
Europe, the Middle East & Africa1,6471,4744,4884,972
Asia/Pacific1,1761,1923,6833,892
3,9403,75511,73812,311
Returns associated with restructuring and other activities—(4)(1)(10)
Net sales$3,940$3,751$11,737$12,301
OPERATING INCOME (LOSS)
By Product Category:
Skin Care$468$269$920$1,238
Makeup66(5)56(9)
Fragrance2966267343
Hair Care(25)(24)(50)(32)
Other119387
5493151,2311,547
Charges associated with restructuring and other activities(18)(18)(28)(33)
Operating income$531$297$1,203$1,514
By Region**(1)****:**
The Americas$(6)$(93)$(243)$(53)
Europe, the Middle East & Africa302176825919
Asia/Pacific253232649681
5493151,2311,547
Charges associated with restructuring and other activities(18)(18)(28)(33)
Operating income$531$297$1,203$1,514

(1) The net sales from the Company's travel retail business are included in the Europe, the Middle East & Africa region, and operating income attributable to these net sales are included in that region and in The Americas. The exception is for net sales and operating income of Dr.Jart+ in the travel retail channel in Korea that are reflected in Korea in the Asia/Pacific region.

THE ESTÉE LAUDER COMPANIES INC.

The following table presents certain consolidated earnings data as a percentage of net sales:

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | --- | ---

Showing the first 8K of 154K characters. Open the full section

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

The information required by this item is set forth in Item 2 of this Quarterly Report on Form 10-Q under the caption Liquidity and Capital Resources - Market Risk and is incorporated herein by reference.

Item 4. Controls and Procedures.

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and to ensure that information required to be disclosed is accumulated and communicated to management, including our principal executive and financial officers, to allow timely decisions regarding disclosure. The Chief Executive Officer and the Chief Financial Officer, with assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of March 31, 2024 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.

As part of our review of internal control over financial reporting, we make changes to systems and processes to improve such controls and increase efficiencies, while ensuring that we maintain an effective internal control environment. There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the third quarter of fiscal 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

For a discussion of legal proceedings, see Notes to Consolidated Financial Statements, Note 9 – Commitments and Contingencies.

THE ESTÉE LAUDER COMPANIES INC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Share Repurchase Program

We are authorized by the Board of Directors to repurchase shares of our Class A Common Stock in the open market or in privately negotiated transactions, depending on market conditions and other factors. The following table provides information relating to our repurchase of Class A Common Stock during the referenced periods:

PeriodTotal Number of Shares Purchased**(1)**Average Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced ProgramMaximum Number of Shares that May Yet Be Purchased Under the Program**(2)**
January 20247,055$133.32—25,073,242
February 2024769147.16—25,073,242
March 2024253147.30—25,073,242
8,077135.08—

(1)Reflects shares that were repurchased by the Company to satisfy tax withholding obligations upon the payout of certain stock-based compensation arrangements.

(2)The Board of Directors has authorized the current repurchase program for up to 256.0 million shares. The total amount was last increased by the Board on October 31, 2018. Our repurchase program does not have an expiration date.

Beginning in December 2022, we temporarily suspended the repurchase of shares of our Class A Common Stock. We may resume repurchases in the future.

Item 5. Other Information.

Trading Arrangements

During the fiscal 2024 third quarter, none of the Company’s directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408(a) of Regulation S-K under the Exchange Act.

Item 6. Exhibits.

Exhibit NumberDescription
31.1Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (CEO).
31.2Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (CFO).
32.1Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (CEO). (furnished)
32.2Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (CFO). (furnished)
101.1The following materials from The Estée Lauder Companies Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Earnings, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements
104The cover page from The Estée Lauder Companies Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 is formatted in iXBRL

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

THE ESTÉE LAUDER COMPANIES INC.
By:/s/ TRACEY T. TRAVIS
Date: May 1, 2024Tracey T. Travis
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)